Insights

Collaboration. A buzzy word these days. Buzz-worthy for sure. Questions like, how do we collaborate more effectively? How do we become more effective interacting with others – especially those not like us or those who don’t share our points of view? Diversity of people equals diversity of thought. This is a good thing, right? Then… Read more »

Never has pathology felt more personal than after walking the halls of USCAP, the premier U.S. Anatomic Pathology conference, this past March. The case studies, the patient tissue specimens illuminated on 10 foot backdrops, the innovative company research scientists there in the flesh, the faces of those working so hard to improve patient care…wow. Pathology… Read more »

The Anatomic Pathology lab has experienced monumental changes in recent years expanding the pathologist’s role beyond a cancer diagnosis to being a key contributor who delivers critical patient results defining treatment selection. The onslaught of genetic and molecular technologies and the increased availability of cancer targeted therapies has further added complexity to the pathologists’ role… Read more »

Since its formation in 1995, the Association for Molecular Pathology (AMP) has been the premier showcase for remarkable technological advancements in the field of molecular diagnostics. The show has seen the evolution of nucleic acid testing from HIV viral load testing in 1996 to a CLIA waived PCR-based strep test in 2015 to the current… Read more »

In the world of personalized diagnostics, history does not necessarily predict the future. Following the much anticipated FDA approval of the first immuno-oncology drug Keytruda® (Merck) for NSCLC patients in October 2015 as a Companion Diagnostic (CDx) for PD-L1 testing , all eyes then went to Bristol Myers Squibb with competitor OPDIVO® as the CheckMate 057… Read more »

Who is the ideal target customer for our product? What features will drive customers to switch to our product? When will our product be utilized in the patient treatment continuum? Where do we stand relative to our competitors? Why do customers resist adoption of our product? How do we better understand what our customers want? These are some of the key… Read more »

Do social media sites really get your company brand recognition in the diagnostics space? The answer is yes! The top two benefits of social media marketing are increasing exposure and company website traffic. Social Media Examiner1 states that 89% of all marketers revealed their social media efforts generate increased exposure for their business and 75% reporting… Read more »

On a brisk 30°F morning in March, I slipped into the most comfortable shoes I could find, to tackle a two day USCAP tradeshow tour in Boston, MA. My first impression was -WOW – USCAP is all grown up. I’ve been attending USCAP since 1999, at a time when the exhibit were in a small… Read more »

As we move through the month of May, Melanoma awareness month, I find myself more keenly aware than ever of the importance of finding a cure. My story began in April when I received a text from my Dad to “call him when I have the chance” quickly followed by a friend’s text to “call… Read more »

In the last decade, tremendous attention has been placed on Personalized Medicine, a new approach using an individual’s genetic makeup to define a more targeted treatment. The value of Companion Diagnostic (CDx) tests as a class of diagnostics driving clinical management of patients is taking hold with CDx tests such as a HER2 helping positive… Read more »